Request Trial
blood-istock-507120082-blackjack3d-
blackjack3d / iStockphoto.com
8 March 2019MedTech

USITC to investigate blood separation devices

The US International Trade Commission (ITC) has instituted an investigation into certain blood separation and cell preparation devices.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

MedTech
Abbott clinches 18-country PI in glucose monitoring feud
9 September 2026   The UPC has handed the medical device company a significant win over continuous glucose monitoring tech, granting a broad provisional injunction after finding that SiBio’s rival system was likely to infringe its European patent.
MedTech
Sun Pharma import ban back in force after Squires intervention
3 September 2026   A decision at the USPTO has cleared the way for renewed enforcement in the drugmaker’s dispute over light-based dermatology tech.
MedTech
Abbott fends off Chinese rival’s patent challenge at UPC
18 August 2026   The European court has backed Abbott in a dispute over glucose-monitoring technology, while offering guidance on a key added-matter issue.


Editor's picks

Exelixis locks down cancer drug exclusivity until 2030 with Fed Circ win
Biotech
Exelixis locks down cancer drug exclusivity until 2030 with Fed Circ win
1 September 2026

Editor's picks

Biotech
Exelixis locks down cancer drug exclusivity until 2030 with Fed Circ win
1 September 2026

More features

Abbott clinches 18-country PI in glucose monitoring feud
UK firm hires head of IP with commercial and technical nous
Italy’s Biofer falls short in Fed Circ appeal over key claim wording
G 1/25: EPO settles controversial patent description question
California votes for law to restrict use of genAI by lawyers
Sun Pharma import ban back in force after Squires intervention
10x Genomics wins latest round in Parse patent dispute
White & Case life sciences co-leader moves firms